Your browser doesn't support javascript.
loading
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial.
Armand, Philippe; Kim, Haesook T; Sainvil, Marie-Michele; Lange, Paulina B; Giardino, Angela A; Bachanova, Veronika; Devine, Steven M; Waller, Edmund K; Jagirdar, Neera; Herrera, Alex F; Cutler, Corey; Ho, Vincent T; Koreth, John; Alyea, Edwin P; McAfee, Steven L; Soiffer, Robert J; Chen, Yi-Bin; Antin, Joseph H.
Afiliação
  • Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kim HT; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sainvil MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lange PB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Giardino AA; Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.
  • Bachanova V; Department of Medical Oncology, University of Minnesota, Minneapolis, MN, USA.
  • Devine SM; Department of Medicine, The Ohio State University Comprehensive Cancer Center Ohio State University, Columbus, OH, USA.
  • Waller EK; Department of Hematology/Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Jagirdar N; Department of Hematology/Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Herrera AF; City of Hope Cancer Center, Duarte, CA, USA.
  • Cutler C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Alyea EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • McAfee SL; Bone Marrow Transplant Unit, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Chen YB; Bone Marrow Transplant Unit, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Br J Haematol ; 173(1): 96-104, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26729448
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article